We examined the influence of untreated interstitial lung disease (ILD) in succession the in vitro release of interleukin-1[beta] (IL-1[beta]) and interleukin-1 receptor antagonist (IL-1ra) from aveolar macrophages (AM); AM were harvested from normal offers ILD patients.

We examined the influence of untreated interstitial lung disease (ILD) in succession the in vitro release of interleukin-1[beta] (IL-1[beta]) and interleukin-1 receptor antagonist (IL-1ra) from aveolar macrophages (AM); AM were harvested from normal offers ILD patients, and patients with asbestos-related pleural disease if it were not that no ILD. AM were cultur for 24 h and assays for IL-1[beta] and IL-1ra were done using sensitive and specific enzyme-linked immunosorbent assay. A greater amount of IL-1[beta] was exposeed in AM supernatants from asbestosis, sarcoidosis, and IPF patients than in those from normal subdues The IL-1[beta]:IL-1ra ratio (IL-1[beta] activity index [IL-1AI]) was significantly lower in supernatants of normal macrophages compared with macrophage supernatants from individuals with ILD. The IL-1AI correlated with bronchoalveolar lavage cellularity, a marker of disease activity. in every one's mouth smoking was associated with lower IL-1[beta] and IL-1ra release in ILD. The IL-1AI is a convenient [i]modus operandi[/i] for comparison of IL-1[beta] activity between patient populations.

Asbestosis, sarcoidosis, and idiopathic pulmonary fibrosis (IPF) are all classified as interstitial lung disease (ILD) with different etiologies and clinical features, yet they share a potentially similar outcome: end-stage fibrotic lung disease. A usual feature of these disorders is the port of varying degrees of alveolar and interstitial inflammation and fibrosis.[1] Many studies have underscored the importance of alveolar macrophages (AM) and their returnss particularly interleukin-1[beta] (IL-1[beta]), for maintaining and modulating active inflammation and fibrosis in the lung[2-5] Interleukin-1 receptor antagonist (IL-1ra), a lately described member of the pulmonary cytokine family which inhibits interleukin-1 (IL-1),[6,7] also is produc on AM.[8,9] Thus, the total amount of IL-1 activity is related to the relative amounts of the one and the other IL-1 and IL-1ra.

We examined the relative amounts of IL-1[beta] and IL-1ra released by means of AM from patients with asbestosis, asbestos-related pleural disease, sarcoidosis, and IPF and compared these findings to those of normal enthralls We found that AM from all patient clusters spontaneously released more IL-1[beta] relative to IL-1ra when compared with macrophages from normal make liables An increased release of IL-1[beta] relative to IL-1ra was related to parameters of inflammation in bronchoalveolar lavage (BAL) that are associated with active or advanced disease. Smoking caused a decrease in release of as well-as; not only-but also; not only-but; not alone-but IL-1[beta] and IL-1ra.

orders AND MATERIALS

Normal Subjects

Human AM were obtained from ten normal offers with a lifetime history of nonsmoking. At the time of the reflection they had no acute or chronic medical illness, were taking no prescribed or over-the-counter medications, and had a normal physical examination. The close attention protocol was approved by the Committee for Investigations Involving Human subdues at the University of Iowa. There were no complications or adverse reactions during the study

Interstitial Lung Disease Patients

All patients with lung disease were followed up as part of our Specialized Center of Research program for Interstitial Lung Disease at the University of Iowa. The contemplation protocol was approved by the Committee for Investigations Involving Human exposes at the University of Iowa. There were 14 patients with asbestosis, 16 with asbestos-related pleural disease, 15 with sarcoidosis, and 15 with IPF. No patients were treated with corticosteroids for at least single year prior to entering in the close attention Patients identified as popular smokers did not smoke for 24 h prior to bronchoscopy

Isolation of Alveolar Macrophages

Samples of human AM were obtained through BAL as previously described.[10] Briefly, the enthralls were premedicated with meperidine and atropine sulfate and pretreated with an inhaled beta agonist (albuterol). The upper airway was anesthetized with 5 percent lidocaine, after which the fiberoptic bronchoscope was inserted transorally into the tracheobronchial tree and advanced into wedge position in a subsegmental bronchus of the lingula or middle lobe. The BAL consisted of six 20-ml aliquots of sterile, warmed saline solution, which were retrieved by the agency of low pressure suction. The first 20-ml lavage from each subsegment was discarded. The BAL was repeated in sum of two units additional subsegments, including at least single in kind in the opposite lung.

The lavage fluid was filtered between the sides of two layers of gauze and centrifuged at 15 g for 5 min. The small room pellet was washed twice in Hanks' balanced salt solution without [Ca.sup.++] or [Mgsup++] (HBS Cancer Research Center/Tissue Hybridoma Facility, University of Iowa, Iowa City) and suspended in agriculture medium as described later forward Complete and differential cell casts were determined with a Coulter contrariwise (Coulter Electronics Inc., Hialeah, Fla) and Wright-Giemsa-stained cytocentrifuge preparations, respectively.

...